June 16, 2023 Comments Off on New patent for DUSA drug LEVULAN Posted in: Patent Added Annual Drug Patent Expirations for LEVULAN Levulan is a drug marketed by Dusa and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for DUSA drug LEVULAN appeared first on DrugPatentWatch…
June 15, 2023 Comments Off on New patent for Novartis drug VIJOICE Posted in: Patent Added Annual Drug Patent Expirations for VIJOICE Vijoice is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug VIJOICE appeared first on DrugPaten…